DHR vs NFLX: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and Netflix, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-16.
Danaher Corporation Β· Healthcare
$195.98
+7.9% upside to fair value
Grade B High Quality
VS
Netflix, Inc. Β· Communication Services
$73.68
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NFLX has more upside to fair value (+45.0%). NFLX trades at a lower forward P/E (23.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR NFLX
Current Price $195.98 $73.68
Fair Value Estimate $211.54 $106.84
Upside to Fair Value +7.9% +45.0%
Market Cap $138.7B $310.2B
Forward P/E 37.8x 23.3x
EV / EBITDA 22.8x 9.2x
Price / Sales 5.6x 6.6x
Price / FCF 26.2x 26.1x
Revenue Growth YoY +3.7% +16.2%
Gross Margin 60.7% 49.0%
Operating Margin 21.0% 29.7%
Return on Equity 7.1% 49.2%
Dividend Yield 0% 0%
FCF Yield 3.81% 3.83%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
NFLX β€” Netflix, Inc.
Netflix, Inc. operates as a leading global streaming entertainment service, delivering a wide variety of TV series, documentaries, and feature films across multiple genres and languages. The company exhibits high business quality with a durable competitive moat supported by strong brand recognition, intangible assets, and network effects. Its recent financial performance shows robust earnings gro…
Accumulation Zones
Metric DHR NFLX
Zone Low $158.66 $80.13
Zone High $179.81 $90.81
In Buy Zone? No Yes
← DHR Research    NFLX Research β†’    All Research